Skip to main content

Drug Safety

      RT @KDAO2011: #EULAR2020 OP0160 Prospective study of Hopkins Lupus Cohort: HCQ blood levels can predict risk for thrombo
      4 years 6 months ago
      #EULAR2020 OP0160 Prospective study of Hopkins Lupus Cohort: HCQ blood levels can predict risk for thrombotic events in SLE. Dr. M Petri advocates this is another reason for monitoring HCQ whole blood levels. Goal HCQ whole blood level should be 1000-1500 ng/mL @rheumnow https://t.co/mM6jsJ2Qmf
      RT @KDAO2011: #EULAR2020 OP0163 Updated Lupus Nephritis EULAR/ERA-EDTA Recc:
      1. T2T:⬇️proteinuria 50%@6 mo,UPCR<
      4 years 6 months ago
      #EULAR2020 OP0163 Updated Lupus Nephritis EULAR/ERA-EDTA Recc: 1. T2T:⬇️proteinuria 50%@6 mo,UPCR<700 mg/g@12mo 2. Class III/IV:MMF, Euro-CYP; MMF+CNI 3. goal pred < 7.5 mg/day@6 mo 4.Class IV: MMF, CNI, CTX 5. Maintain w/MMF, AZP 6.🔃renal Bx w/refract. dz @RheumNow https://t.co/tGaSIDG1ji
      RT @KDAO2011: How long should you keep pts on TCZ for GCA after remission has been achieved? @RheumNow #eular2020
      4 years 6 months ago
      How long should you keep pts on TCZ for GCA after remission has been achieved? @RheumNow #eular2020
      RT @KDAO2011: #EULAR2020 Dr. Kimme Hyrich reviews the EULAR #COVID19 Registry "Most individuals with rheumatic diseases
      4 years 6 months ago
      #EULAR2020 Dr. Kimme Hyrich reviews the EULAR #COVID19 Registry "Most individuals with rheumatic diseases receiving immunosuppressive therapies recover from COVID19" @rheumnow https://t.co/EdVLUMyHhF
      RT @uptoTate: SELECT-PSA-2 results: UPA15 &amp; UPA30 showed improvement across PsA domains vs PBO through Wk 24. No ne
      4 years 6 months ago
      SELECT-PSA-2 results: UPA15 & UPA30 showed improvement across PsA domains vs PBO through Wk 24. No new safety signals were identified. Check out abstract #OP0223 for the MDA/ACR50/ACR70 responses. #EULAR2020 @RheumNow https://t.co/UAx2tkKSZI
      RT @uptoTate: Study out of Switzerland finds lower response rates to TNFi in women with nr-axSpA vs men. Poster #THU0383
      4 years 6 months ago
      Study out of Switzerland finds lower response rates to TNFi in women with nr-axSpA vs men. Poster #THU0383 #EULAR2020 @RheumNow https://t.co/uWNqwqamQM https://t.co/pgnhCaw9f6
      RT @uptoTate: This Spanish study of 255 SpA pts found that acute unilateral anterior uveitis was the most common pattern
      4 years 6 months ago
      This Spanish study of 255 SpA pts found that acute unilateral anterior uveitis was the most common pattern, primarily in HLA B27+. NO difference in incidence between SEC and TNFi treated pts. #EULAR2020 @RheumNow Poster #THU0388 https://t.co/OMfG8atfE4
      RT @uptoTate: nr-axSpA pts with active inflammation improved with IXE. Drug efficacy did not change in pts with elevated
      4 years 6 months ago
      nr-axSpA pts with active inflammation improved with IXE. Drug efficacy did not change in pts with elevated CRP or sacroiliitis or both. #EULAR2020 @RheumNow poster #THU0395 https://t.co/ap6Wy2eNBL https://t.co/zLoNHuSVV5
      RT @uptoTate: COAST-V and COAST-X trial results: Both TNFi experienced and naive AS pts had better work productivity com
      4 years 6 months ago
      COAST-V and COAST-X trial results: Both TNFi experienced and naive AS pts had better work productivity compared to PBO. #EULAR2020 @RheumNow poster #THU0396 https://t.co/UPDpLqCSkG https://t.co/UTLzxxTG8K
      RT @uptoTate: 10 ReA pt study out of India reviewing ETN-b found that all pts (previously on ETN) responded to biosimila
      4 years 6 months ago
      10 ReA pt study out of India reviewing ETN-b found that all pts (previously on ETN) responded to biosimilar med without new safety signals. Further details are here on abstract #AB0632 https://t.co/lRA2IDvU4H #EULAR2020 @RheumNow https://t.co/QyhwBzBBH3
      ×